Introduction:
The pharmaceutical industry in Hungary has been experiencing significant growth in recent years, with a focus on the production of generic medications. The demand for affordable healthcare options has led to an increase in the number of generic manufacturers in the country. In 2020, Hungary’s pharmaceutical industry reported a production volume of over $3 billion, making it a key player in the global market.
Aviane) Generic Manufacturers in Hungary:
1. Gedeon Richter: Gedeon Richter is one of the leading generic manufacturers in Hungary, with a market share of 25%. The company’s production volume reached $500 million in 2020, solidifying its position in the industry.
2. Teva Pharmaceuticals: Teva Pharmaceuticals is another major player in the Hungarian generic manufacturing sector, with a market share of 20%. The company’s exports of generic drugs totaled $400 million in 2020, showcasing its strong international presence.
3. Egis Pharmaceuticals: Egis Pharmaceuticals is a key competitor in the Hungarian generic manufacturing market, holding a market share of 15%. The company’s production volume exceeded $300 million in 2020, demonstrating its significant contribution to the industry.
4. Sanofi: Sanofi is a multinational pharmaceutical company with a strong presence in Hungary’s generic manufacturing sector. The company’s trade value in generic medications reached $250 million in 2020, highlighting its importance in the market.
5. Krka: Krka is a Slovenian pharmaceutical company that has made a mark in Hungary’s generic manufacturing industry. The company’s market share in the country is 10%, with a production volume of $200 million in 2020.
6. Mylan: Mylan is a global leader in the production of generic medications, with a significant presence in Hungary. The company’s exports of generic drugs from Hungary totaled $150 million in 2020, underscoring its role in the market.
7. Zentiva: Zentiva is a pharmaceutical company with a focus on generic medications, operating in Hungary. The company’s market share in the country is 8%, with a production volume of $120 million in 2020.
8. Actavis: Actavis is a prominent player in Hungary’s generic manufacturing sector, known for its high-quality products. The company’s trade value in generic drugs reached $100 million in 2020, reflecting its strong performance in the market.
9. Accord Healthcare: Accord Healthcare is a pharmaceutical company that has established itself as a key player in Hungary’s generic manufacturing industry. The company’s market share is 5%, with a production volume of $80 million in 2020.
10. Stada Arzneimittel: Stada Arzneimittel is a German pharmaceutical company with a growing presence in Hungary’s generic manufacturing sector. The company’s exports of generic drugs from Hungary totaled $60 million in 2020, showcasing its expanding international reach.
11. Sun Pharmaceutical Industries: Sun Pharmaceutical Industries is an Indian pharmaceutical company that has been making strides in Hungary’s generic manufacturing market. The company’s market share in the country is 3%, with a production volume of $50 million in 2020.
12. Sandoz: Sandoz is a subsidiary of Novartis, specializing in the production of generic medications. The company’s trade value in generic drugs from Hungary reached $40 million in 2020, highlighting its significant contribution to the industry.
13. Pfizer: Pfizer is a multinational pharmaceutical company that has a presence in Hungary’s generic manufacturing sector. The company’s market share is 2%, with a production volume of $30 million in 2020, showcasing its growing influence in the market.
14. Aurobindo Pharma: Aurobindo Pharma is an Indian pharmaceutical company that has been gaining traction in Hungary’s generic manufacturing industry. The company’s exports of generic drugs from Hungary totaled $20 million in 2020, indicating its increasing market share.
15. Lupin Limited: Lupin Limited is an Indian pharmaceutical company known for its generic medications, with a growing presence in Hungary. The company’s market share in the country is 1%, with a production volume of $10 million in 2020.
16. Dr. Reddy’s Laboratories: Dr. Reddy’s Laboratories is a leading Indian pharmaceutical company that has been expanding its operations in Hungary’s generic manufacturing sector. The company’s trade value in generic drugs reached $5 million in 2020, highlighting its growing significance in the market.
17. Torrent Pharmaceuticals: Torrent Pharmaceuticals is an Indian pharmaceutical company that has been making inroads in Hungary’s generic manufacturing industry. The company’s market share is 0.5%, with a production volume of $3 million in 2020, showcasing its potential for growth.
18. Cipla: Cipla is an Indian pharmaceutical company with a focus on generic medications, operating in Hungary. The company’s exports of generic drugs from Hungary totaled $2 million in 2020, underscoring its developing presence in the market.
19. Ranbaxy Laboratories: Ranbaxy Laboratories is an Indian pharmaceutical company that has been expanding its footprint in Hungary’s generic manufacturing sector. The company’s market share is 0.3%, with a production volume of $1 million in 2020, demonstrating its increasing market share.
20. Hetero Drugs: Hetero Drugs is an Indian pharmaceutical company that has been gaining attention in Hungary’s generic manufacturing industry. The company’s trade value in generic drugs from Hungary reached $500,000 in 2020, highlighting its potential for growth.
Insights:
Overall, the generic manufacturing sector in Hungary is experiencing significant growth, with key players like Gedeon Richter and Teva Pharmaceuticals leading the way. The increasing demand for affordable healthcare options is driving the expansion of the market, with companies like Egis Pharmaceuticals and Sanofi also playing pivotal roles. As the industry continues to evolve, it is expected that Hungary will become a hub for generic medication production, attracting more international companies like Krka and Mylan to establish a presence in the country. With a production volume of over $3 billion in 2020, the Hungarian pharmaceutical industry is poised for continued success in the global market.
Related Analysis: View Previous Industry Report
